UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION~~

~~Washington,~~SECURITIES ~~D.C.~~AND ~~20549~~EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________

FORM 8-K

________________________

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of the ~~Securities Exchange Act of 1934~~

~~Date~~Securities ofExchange ~~Report~~Act ~~(Date~~ of ~~earliest event reported): March 8, 2024~~1934

~~Free~~Date ~~Flow,~~of ~~Inc.~~Report (~~Exact~~Date ~~Name~~ of ~~Registrant~~Earliest asevent ~~Specified~~Reported): inMay ~~its~~28, ~~Charter)~~2024

Delaware		000-54868		45-3838831
(State of Incorporation)		(Commission File No.)		(IRS Employer Identification Number)

Free Flow USA, Inc.

(~~Address~~Exact name of ~~Principal~~registrant ~~Executive~~as ~~Offices~~specified in its charter)

6269 Caledon Road

Delaware	000-54868	45-3838831
(State of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

~~King~~9243 ~~George~~John F. Kennedy Blvd., VASuite ~~22485~~104

~~(Registrant’s~~North ~~Telephone~~Bergen, ~~Number)~~NJ 07047

(~~703)~~Address ~~789~~of ~~3344~~principal executive offices)

~~Callie~~Phone: ~~Tempest~~+(703) ~~Jones, Esq.~~789-3344

~~175~~(Registrant’s S.telephone ~~Main Street, # 1410~~number)

~~Salt~~Check ~~Lake~~the ~~City,~~appropriate UTbox ~~84111~~below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (~~801~~§230.405 of this chapter) ~~303~~or ~~5721~~Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

~~---------------------------------------~~Emerging growth company x

~~(Name~~If an emerging growth company, ~~Address~~indicate ~~and~~by ~~Telephone~~check ~~Number~~mark ofif ~~Person~~the ~~Authorized~~registrant has elected not to ~~Receive~~use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

~~Notice~~Securities ~~and~~registered ~~Communications~~pursuant onto ~~Behalf~~Section 12(b) of the ~~Person(s)~~Act: ~~Filing Statement)~~None.

~~Check~~Item ~~the~~5.02 ~~appropriate~~– ~~box~~Departure ~~below~~Of ifDirectors ~~the~~Or ~~Form~~Principal ~~8-K~~Officers; ~~filing~~Election isOf ~~intended~~Directors; toAppointment ~~simultaneously~~Of ~~satisfy~~Principal ~~the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):~~Officers

☐On ~~Written~~August ~~communications~~23, ~~pursuant~~2024, toFree ~~Rule~~Flow, ~~425~~Inc., ~~under~~(the “Company”) appointed Dr. Ravinder Tikoo as a Director and Chairman of the ~~Securities~~Board ~~Act~~of ~~(17~~Directors ~~CFR~~of ~~230~~the Company.~~425)~~ Please find Dr. Tikoo’s information below.

☐Ravinder ~~Soliciting~~Tikoo, ~~material~~M.D., ~~pursuant~~age to57, ~~Rule~~is ~~14a~~a board-12certified ~~under~~neurologist who has been in private practice since 2008. From 2002 to 2017, Dr. Tikoo served as Assistant Clinical Professor at the ~~Exchange~~New ~~Act~~York ~~(17~~Hospital/Weill ~~CFR~~Medical ~~240~~College of Cornell University in New York.~~14a-12)~~ From 1997 to 2001, Dr. Tikoo served as Assistant Neurology Attending/Instructor in Neurology for the New York University Medical Center, Department of Neurology.

☐After ~~Pre-commencement~~graduating ~~communications~~with ~~pursuant~~honors towith ~~Rule~~a ~~14d-2(b)~~BS ~~under~~in Chemistry and Biochemistry from the ~~Exchange~~University ~~Act~~of ~~(17~~Iowa, ~~CFR~~Dr. ~~240~~Tikoo continued his education there and received his medical degree in 1991.~~14d-2(b))~~ He completed an internship in general medicine at Northwestern University Medical Center, followed by a residency in neurology at the New York Hospital/Cornell Medical Center. Dr. Tikoo then completed a fellowship in neurology, also at Cornell Medical Center.

☐Item ~~Pre-commencement~~5.03 ~~communications~~– ~~pursuant~~Amendments to ~~Rule~~Articles ~~13e-4(c)~~of ~~under~~Incorporation ~~the~~or ~~Exchange~~Bylaws; ~~Act~~Change ~~(17~~in ~~CFR~~Fiscal ~~240.13e-4(c))~~Year

~~Section~~On 1May ~~– Registrant’s~~28, ~~Business~~2024, the Company filed a Certificate of Renewal and ~~Operations~~Revival of Charter with the Delaware Department of State, Division of Corporations in which the name of the corporation was changed from Free Flow, Inc. to Free Flow USA, Inc.

Item 18.01 ~~Entry~~– ~~into~~Other ~~a Material Definitive Agreement.~~Events

~~a)On~~As ~~March 6, 2024, Accurate Auto Parts, Inc. a wholly owned subsidiary~~ of ~~Free~~August ~~Flow~~15, ~~Inc. (the “Registrant”)~~2024, ~~transacted~~ ~~a Sales Contract (~~the ~~“Sales~~Company’s ~~Contract”)~~principle ~~executed~~executive onoffices ~~March~~have 4,moved ~~2024~~from ~~pursuant to which the Registrant sold the CRE asset addressed as~~ 6269 Caledon Road, King George, VAVirginia 22485 ~~owned~~to by9243 ~~Accurate~~John ~~Auto Parts, Inc~~F. toKennedy ~~Trusted Auto Parts~~Blvd., ~~LLC~~Suite ~~(the “Purchaser”)~~104, ~~with~~North ~~a principal place of business at 12689 Catawba Drive~~Bergen, ~~Woodbridge,~~New VAJersey ~~22192 for a gross price of $1,700,000~~07047.

~~b)The~~Item ~~Registrant~~9.01 ~~continues its~~Financial ~~operations~~Statements ~~by buying inventory from other Recycling Facilities~~ and ~~act as a trader in the same line of business~~Exhibits.

SIGNATURES

Exhibit No.		Description
3.1		C ertificate of Renewal and Revival filed May 28, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL Document)

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~ SIGNATURE

					FREE FLOW, INC.
					(Registrant)
Date: March 8, 2024					Sabir Saleem, CEO

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Free Flow, Inc.

Date: August 27, 2024By: /s/ Sabir Saleem

Sabir Saleem

President & CEO

Filing Compare · Free Flow USA, Inc.